4//SEC Filing
BRAWLEY OTIS W 4
Accession 0001209191-23-038435
CIK 0001806952other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:41 PM ET
Size
5.6 KB
Accession
0001209191-23-038435
Insider Transaction Report
Form 4
BRAWLEY OTIS W
Director
Transactions
- Award
Option (right to buy)
2023-06-16+65,000→ 65,000 totalExercise: $3.19Exp: 2033-06-15→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 16, 2023 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 16, 2023, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001213029
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:41 PM ET
- Size
- 5.6 KB